New heart valve repair device could help High-Risk patients avoid surgery
NCT ID NCT07243197
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device called DragonFly M2 to repair leaky mitral valves in people with moderate-to-severe or severe mitral regurgitation who are at high risk for surgery. The device is inserted through a blood vessel, avoiding open-heart surgery. The study will check if the device is safe and works well in 53 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE (MV) REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital Chinese Academy of Medical Sciences
Shenzhen, Guangdong, 518000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tiny implant fix complex heart valve leaks without open surgery?
- Can a tiny implant fix a leaky heart valve without open surgery?
- Can a new device fix leaky heart valves that are hard to treat?
- A tiny chest incision, a beating heart: can a new technique fix leaky valves without open surgery?
- Holograms may help doctors place heart devices with greater precision
- Can a heart procedure cut stroke risk after valve repair? new trial aims to find out